Company Quick10K Filing
Panhandle Eastern Pipe Line
10-Q 2020-09-30 Filed 2020-11-05
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-02-21
10-Q 2019-09-30 Filed 2019-11-07
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-02-22
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-02-23
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-04
10-K 2016-12-31 Filed 2017-02-24
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-08
10-Q 2016-03-31 Filed 2016-05-06
10-K 2015-12-31 Filed 2016-02-26
10-Q 2015-09-30 Filed 2015-11-06
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-08
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-07
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-02-27
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-03-01
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-09
10-K 2011-12-31 Filed 2012-02-24
10-Q 2011-09-30 Filed 2011-11-08
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-02-25
10-Q 2010-09-30 Filed 2010-11-04
10-Q 2010-06-30 Filed 2010-08-05
10-Q 2010-03-31 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-03-01
8-K 2020-11-04
8-K 2020-08-05
8-K 2020-05-11
8-K 2020-02-19
8-K 2019-11-06
8-K 2019-08-07
8-K 2019-07-02
8-K 2019-05-08
8-K 2019-02-20
8-K 2018-11-07
8-K 2018-08-08
8-K 2018-05-09
8-K 2018-02-21

Panhandle Eastern Pipe Line Financials

PEPL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
1Life Healthcare (ONEM)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
20 20 Global (TWGL)
111 (YI) 0% 1,546 323 0 0 0 0 -854
1 800 Flowers Com (FLWS) 944 42% 13.3 6% 665 336 1,266 534 37 75 1,001
10x Genomics (TXG) 4,805 75% -490.3 -2% 573 151 61 46 -10 -9 4,357
12 Retech (RETC) 0 32% -0.1 -1,385% 1 20 1 0 -15 -15 1
1347 Property Insurance Holdings (PIH) 34 0% 0.4 -5% 164 108 18 0 -8 -8 -3
21st Century Oncology Holdings (RTSX)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 19 23 27 7 -3 -1 3
1895 Bancorp of Wisconsin (BCOW) 46,153 12,508.1 -0% 441 383 0 0 -0 4 46,142
1st Constitution Bancorp (FCCY) 165 0% 4.4 1% 1,343 1,204 0 0 14 33 144
024 Pharma (EEIG)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash0000017432553247653032218543915216020420
Accounts Receivable697176796767635551515851404148453942464636374543383943464042
Inventory103831151471381652031601471151198310699113891321231791441169515091868698597070
PP&E4,0334,0684,0884,1114,1424,1544,2073,3163,3313,3603,3953,4033,4283,4563,3383,0263,3403,3523,2423,2333,2893,3173,1993,2073,2303,2513,1963,1973,2173,250
Assets4,6284,6714,6757,1357,1786,6346,0726,6586,5996,5576,1916,1296,1495,8625,2945,2725,2934,7953,8333,8123,7073,7083,1873,1103,1043,1062,9952,9372,9272,952
Accounts Payable131113
Long-Term Debt1,1691,1691,6241,7601,7601,4931,4881,0281,0231,2031,2011,1951,1901,1841,1781,1721,1661,1601,1531,1471,141830818409253252401248248247
Liabilities2,9152,9192,8833,0533,0262,4452,5183,7303,6823,6303,2663,1723,1972,9872,3552,2972,3632,3922,3722,3311,8421,7431,7141,6911,6331,5191,4741,392
Stockholders' Equity1,7121,7511,7924,0824,1524,1893,5542,9282,9172,9272,9252,9572,9522,8752,9392,9752,9302,4031,4611,4811,3451,3671,3901,4151,3621,4181,4531,560
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue190193219178129132143155128126139141124120129128104110138149134137154158139135
Cost of Revenue0000
Gross Profit137158139135
R&D
SG&A1210811107109910688
Tax2322291061481225-28231697-411252-28218981711-445
Net Income403547426937-351623-731-67624361513-7051484-71342223295052475
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating9839130-1767703968-11292115221593149219847616239155
Cash Investing-98-22-8-1-31-55-2122-26-110-25-165-22-6049-43153-20-11-6-14-20-30
Cash Financing-0-17-65-24-1300-125000-187-79-31-61-64-21-127